MIRA Pharmaceuticals, Inc.
MIRA
$1.41
-$0.01-0.70%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -39.44% | -57.42% | -31.65% | 46.77% | -19.98% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -35.44% | 189.95% | -36.84% | -20.26% | -41.39% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -38.98% | -52.73% | -31.75% | 44.29% | -21.04% |
|
|||||
Total Current Assets | -38.98% | -52.73% | -31.75% | 44.29% | -21.04% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | -57.45% | -11.02% |
Total Assets | -37.99% | -52.10% | -31.49% | 41.48% | -20.83% |
|
|||||
Total Accounts Payable | 196.43% | -86.08% | 4.40% | -11.42% | 22.91% |
Total Accrued Expenses | -- | -- | -- | -- | 0.00% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 181.07% | -85.32% | 4.40% | -13.03% | 22.18% |
|
|||||
Total Current Liabilities | 181.07% | -85.32% | 4.40% | -13.03% | 22.18% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 181.07% | -85.32% | 4.40% | -13.03% | 22.18% |
|
|||||
Common Stock & APIC | 2.52% | 2.80% | 3.38% | 12.63% | 2.88% |
Retained Earnings | -4.97% | -6.12% | -8.97% | -8.28% | -7.35% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -55.97% | -41.17% | -38.44% | 61.05% | -29.71% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -55.97% | -41.17% | -38.44% | 61.05% | -29.71% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -55.97% | -41.17% | -38.44% | 61.05% | -29.71% |
|